Pathogenesis meetings & conferences

12th International Symposium on Myelodysplastic Syndromes

May 8-11, 2013 Berlin, Germany

The scientific program is designed to meet the aims of The MDS Foundation, which are “to provide an ongoing exchange of information relating to MDS and provides patients with referrals to Centers of Excellence, contact names for available clinical trials, sharing of new research and treatment options between physicians, and extension of educational support to both physicians and patients." The format will include plenary sessions (including a nursing symposium), debates, case-based discussion, topical workshops, oral and poster presentations.

This 12th symposium will again promote the clinical application of existing knowledge and the acquisition of new knowledge by bringing together clinicians, scientists and educators from around the world who deal with MDS.

Clinical Management: General
Diagnosis (including morphology, flow cytometry, molecular)
Epidemiology (including demographics, quality of life, co-morbidity)
Pathogenesis (including molecular, immunological, cellular, animal models, other)
Childhood MDS
Prognostic Factors and Models
Supportive Care including Iron Chelation Therapy
Stem Cell Transplantation
Therapy (including high-risk MDS, low-risk MDS, other)
Other

14th MS Nurse Workshop

October 9, 2012 Lyon, France

Aim of the course

This is an educational program created to encourage the dissemination of scientific knowledge among nurses working in the field of multiple sclerosis (MS). Disease management in research and clinical practice, with a special emphasis on the nurses’ crucial role, will be reviewed. Management of main signs and symptoms of the disease, such as spasticity, pain, psychosocial distress, cognitive impairment and genitourinary problems will be addressed both from the physician and nurse perspective.

Learning objectives

This course will offer to participants:

Updates on etiologic factors and pathogenetic mechanisms
An overview of diagnostic tools used in patient screening and follow-up
A review of research methodology in MS
Criteria to optimize treatment administration

Target audience

Nurses involved in the treatment of persons with multiple sclerosis.

Scientific Secretariat

Serono Symposia International Foundation
Salita di San Nicola da Tolentino, 1/b
00187 Rome, Italy

Project manager: Serena Dell’Ariccia
T +39-06-420 413 251 | F +39-06-420 413 677
E-mail: info@seronosymposia.org

Serono Symposia International Foundation is a Swiss Foundation with headquarters in 14, rue du Rhône, 1204 Geneva, Switzerland

3rd Annual International Conference on Advances in Biotechnology (BioTech 2013)

18 - 19 March 2013 Singapore

Biotechnology is a field of applied biology that involves the use of living organisms and bioprocesses in engineering, technology, medicine and other fields requiring bioproducts. The concept encompasses a wide range of procedures for modifying living organisms according to human purposes - going back to domestication of animals, cultivation of plants, and "improvements" to these through breeding programs that employ artificial selection and hybridization.

This multi-disciplinary conference aims to provide a challenging forum and vibrant opportunity for researchers and industry practitioners to share their original research results and practical development experiences on specific new challenges and emerging issues.

Topics of interest include, but are not limited to:

Pharmaceutical / Medicine

• Structural Biology
• Proteomics
• Cell Cycle and Oncology
• Medical Microbiology
• Diagnostic Pathology
• Clinical Chemistry
• Haematology
• Diagnostic Imaging
• Medical Imaging and Methods
• Sonography
• Molecular and Cell Biology
• Biochemistry
• Immunology
• Genetics
• Neurobiology
• Drug production
• Pharmacogenomics
• Gene therapy
• Factors for transcribing DNA into RNA
• Monoclonol antibodies
• Pathogenesis of Human Diseases
• Presymptomatic testing

Food and Agriculture

• Genetic engineering
• Genomics
• Tissue culture
• Cell fusion
• Molecular biology
• Enzymology
• Fermentation processes
• Instrumentation and diagnostic methods
• Food processing
• Biofertilizer
• Waste Technology
• Environment Control
• Pest and diseases resistant crop
• High value addictives and chemical products
• Immunological techniques
• Signal transduction
• Conjugation
• Classical mutagenesis
• Conjugation process
• Hybridisation

CONFERENCE SECRETARIAT

Global Science & Technology Forum (GSTF)
10 Anson Road, International Plaza,
Singapore 079903
DID : +65 6327 0166
Fax : +65 6327 0162

For Conference Information info@advbiotech.org
For Registration, Accommodation or Visa Assistance secretariat@advbiotech.org

XX World Federation of Neurology World Congress on Parkinson's Disease and Related Disorders

December 8-11, 2013 Geneva, Switzerland

Integration by Translation

The XX WFN World Congress on Parkinson's Disease and Related Disorders is an innovative educational forum for learning about the latest research and discoveries in etiology, pathogenesis, potential diagnostic markers and treatment modalities of Parkinson’s Disease and its related disorders.

Sponsored by the World Federation of Neurology’s Association of Parkinsonism and Related Disorders, this biennial event is internationally recognized for the scope of its program, which covers a wide range of topics and consists of the world’s preeminent experts. Being held in beautiful Geneva, this congress is sure to attract a large faculty of distinguished scientists, clinicians and allied health experts from Europe and around the world.

Kenes International
1-3 Rue de Chantepoulet,
PO Box 1726, CH-1211,
Geneva 1, Switzerland
Tel: + 41 22 908 0488
Fax: + 41 22 906 9140
E-mail: parkinson@kenes.com

24th Annual Fanconi Anemia Research Fund Scientific Symposium

September 27 – 30, 2012 Denver, Colorado

Session topics may include:

Bone marrow failure and transplantation
Gene therapy and stem cell expansion
Functions of FA proteins
Role of environmental and endogenous mutagens
Small molecule development and therapeutics
Other experimental therapies
Squamous cell carcinoma and HPV
Other cancers in FA
Molecular pathogenesis and control of hematopoietic and epithelial neoplasms
Pathophysiology and treatment of endocrinopathies

Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2012)

September 9-12 San Francisco, California

Intended Audience

ICAAC 2012 is designed to meet the needs of health care professionals, particularly physicians, clinical microbiologists, researchers, and pharmacists, specializing in infectious diseases. Current trends will be covered regarding:

Antimicrobial Resistance

Mycology

Clinical Trials

Nosocomial Infections

Community-Acquired Infections

Parasitology

Epidemiology

Pharmacology

Susceptibility Studies

HIV/AIDS and other Retroviruses

Vaccines and Immunology

Laboratory Diagnostics

Virology

Microbial Pathogenesis

Questions or Comments?

American Society for Microbiology- Meetings Department
1752 N Street NW
Washington, DC 20036

icaac@asmusa.org
(202) 737-3600

Li Ka Shing Institute of Virology and Gairdner Foundation Symposium: Meeting the Challenge of Emerging, Acute and Persistent Viral Diseases

May 31 & June 1, 2012 Allard Theatre, Katz Centre for Health Research, University of Alberta, Edmonton, Canada

The symposium will focus on the viral pathogenesis, immune responses and potential of novel antivirals, and vaccines both prophylactic and therapeutic on these viruses.

Address & Contact Information

Li Ka Shing Institute of Virology
6010 Katz Centre for Health Research
Edmonton, AB T6G 2E1
CANADA

Phone: +1 (780) 492-1084
Fax: +1 (780) 492-5304

Email: karin.fodor@ualberta.ca

Controversies in Rheumatology & Autoimmunity

April 4-6, 2013 Budapest, Hungary

CORA 2013 unites experts in the fields of rheumatology, allergology and immunology. Join top speakers as they discuss controversial aspects in pathogenesis, clinical features, outcomes and the treatment of rheumatic and autoimmune diseases.

Congress Secretariat

Kenes International
1-3, Rue de Chantepoulet
P.O. Box 1726
CH-1211 Geneva 1
Switzerland
Tel: +41 22 908 0488
Fax: +41 22 906 9140
E-mail: cora@kenes.com

The Lung – a Pivotal Player in Systemic Inflammatory Disorders

June 11-12, 2012 Solna, Sweden

As representatives of the Executive Committee and Advisory Board of this symposium we are happy to invite you to participate in this unique symposium on systemic inflammatory disorders. It is arranged by representatives from both clinic and research, and by specialists in pulmonary medicine, rheumatology and neurology enabling fruitful information and discussions on general topics as well as on specific issues. The high quality of the meeting is reflected by the use of the trade mark “Karolinska Institutet Conferences”, and internationally well recognized speakers further guarantee that interesting data will be presented.

The symposium is arranged as a result of recent data on how smoking and genetic factors have a great impact not only on the lungs but also on other organs affected in systemic inflammatory disorders. These findings call for more intensive collaborations in the future between clinicians representing different specialties’ and for research of truly translational character.

Introductory speeches will be given to inform about common clinical findings which may reflect lung involvement in systemic disorders, and how they can be established. Smoking and co-morbidity in systemic inflammatory disorders will be discussed, and the role of interstitial lung involvement in myositis, rheumatoid arthritis and multiple sclerosis will be elucidated. Can smoking related changes in the lung trigger joint inflammation, or increase the risk of getting myositis or MS? Another topic is the genetic and possible etiological background in sarcoidosis.

Up-to-date treatment of interstitial lung involvement, pros and cons, and the effects of smoking on treatment will be debated followed by an overview of failures and successes of smoking cessation programs.

You will also at a poster-viewing session be given the opportunity to informally discuss your own abstract. Can you really afford not to participate?

Congrex Sweden AB
Attn: The Lung

Telephone/fax
T: +46 8 459 66 00
F: +46 8 661 91 25

General requests
thelung2012@congrex.com
Registration and hotel matters
thelung2012.registration@congrex.com

 55th Annual Thomas L. Petty Aspen Lung Conference

“Mechanics and Mechanisms of Pulmonary Hypertension”

June 6-9, 2012 Aspen, Colorado

The theme of the 55th Meeting of the Thomas L. Petty Aspen Lung Conference is “Mechanics and Mechanisms of Pulmonary Hypertension”. Emphasizing the integration of basic, translational and clinical sciences, the meeting will focus on the utilization of new strategies and technologies to investigate the pathogenesis, treatments and outcomes of pulmonary hypertension. Anchored by twelve “state-of-the-art” presentations delivered by international experts with accompanying abstract presentations, the thematic sessions will address epidemiology, progenitor cell biology, the role of inflammation, genetic somatic mutations and epigenetics, the impact of right ventricle (RV) dysfunction and RV-pulmonary artery coupling, the etiology and implication of PAH in WHO class III disease and prospects for novel disease modifying and preventive therapies. The Conference Summary will be presented by Werner Seeger, M.D., Professor of Medicine, Chief of the Department of Internal Medicine at the University Giessen Hospital, Germany. Dr. Seeger is Chairman of the Lung Center, and the Director of the Max Planck Institute for Heart and Lung Research and one of the world’s preeminent experts in the field of pulmonary vascular disease.

For more information, contact:

Todd Bull, M.D., c/o Jeanne Cleary
Thomas L. Petty Aspen Lung Conference
Anschutz Medical Campus, Research 2, Box C272, 9th Floor
12700 East 19th Avenue, Aurora, CO 80045
Phone: (303) 358-2797. Fax: (720) 851-1034. E-Mail:
Jeanne.Cleary@ucdenver.edu

or visit our website at
www.aspenlungconference.org